SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-22-024668
Filing Date
2022-07-01
Accepted
2022-06-30 21:28:10
Documents
94
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A brhc10039222_10ka.htm   iXBRL 10-K/A 2249555
2 EXHIBIT 23.1 brhc10039222_ex23-1.htm EX-23.1 4159
3 EXHIBIT 31.1 brhc10039222_ex31-1.htm EX-31.1 9752
4 EXHIBIT 31.2 brhc10039222_ex31-2.htm EX-31.2 9961
5 EXHIBIT 32.1 brhc10039222_ex32-1.htm EX-32.2 3698
6 EXHIBIT 32.2 brhc10039222_ex32-2.htm EX-32.2 3595
  Complete submission text file 0001140361-22-024668.txt   11951895

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA btx-20211231.xsd EX-101.SCH 88504
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE btx-20211231_cal.xml EX-101.CAL 84895
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btx-20211231_def.xml EX-101.DEF 418071
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20211231_lab.xml EX-101.LAB 1120511
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20211231_pre.xml EX-101.PRE 655268
88 EXTRACTED XBRL INSTANCE DOCUMENT brhc10039222_10ka_htm.xml XML 2249599
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-11460 | Film No.: 221059371
SIC: 2834 Pharmaceutical Preparations